- Home
- TBPH vs CLPT Comparison
TBPH vs CLPT Comparison
Compare TBPH & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBPH
- CLPT
- Stock Information
- Founded
- TBPH 2013
- CLPT 1998
- Country
- TBPH United States
- CLPT United States
- Employees
- TBPH N/A
- CLPT N/A
- Industry
- TBPH Biotechnology: Pharmaceutical Preparations
- CLPT Medical/Dental Instruments
- Sector
- TBPH Health Care
- CLPT Health Care
- Exchange
- TBPH Nasdaq
- CLPT Nasdaq
- Market Cap
- TBPH 464.5M
- CLPT 315.7M
- IPO Year
- TBPH N/A
- CLPT N/A
- Fundamental
- Price
- TBPH $10.67
- CLPT $11.63
- Analyst Decision
- TBPH Buy
- CLPT Strong Buy
- Analyst Count
- TBPH 4
- CLPT 3
- Target Price
- TBPH $14.50
- CLPT $25.00
- AVG Volume (30 Days)
- TBPH 305.1K
- CLPT 295.1K
- Earning Date
- TBPH 08-04-2025
- CLPT 08-06-2025
- Dividend Yield
- TBPH N/A
- CLPT N/A
- EPS Growth
- TBPH N/A
- CLPT N/A
- EPS
- TBPH N/A
- CLPT N/A
- Revenue
- TBPH $65,266,000.00
- CLPT $32,235,999.00
- Revenue This Year
- TBPH $43.18
- CLPT $23.97
- Revenue Next Year
- TBPH N/A
- CLPT $27.52
- P/E Ratio
- TBPH N/A
- CLPT N/A
- Revenue Growth
- TBPH 6.11
- CLPT 23.22
- 52 Week Low
- TBPH $7.44
- CLPT $5.11
- 52 Week High
- TBPH $11.82
- CLPT $19.22
- Technical
- Relative Strength Index (RSI)
- TBPH 57.88
- CLPT 43.19
- Support Level
- TBPH $10.44
- CLPT $10.66
- Resistance Level
- TBPH $11.00
- CLPT $14.23
- Average True Range (ATR)
- TBPH 0.30
- CLPT 0.68
- MACD
- TBPH -0.05
- CLPT -0.10
- Stochastic Oscillator
- TBPH 23.15
- CLPT 27.17
About TBPH Theravance Biopharma Inc.
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.